ACME Laboratories (DHA:ACMELAB) Cyclically Adjusted Book per Share: BDT116.25 (As of Mar. 2026)


DHA:ACMELAB ACME Laboratories Ltd DHA:ACMELAB
90 GF Score
Price BDT83.30
GF Value BDT125.35
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ACME Laboratories Cyclically Adjusted Book per Share?

ACME Laboratories DHA:ACMELAB -1.19% 90 Cyclically Adjusted Book per Share is BDT116.25 as of Mar. 2026. GuruFocus rates DHA:ACMELAB with a GF Score™ of 90/100 and a GF Value™ of BDT125.35 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ACME Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was BDT132.273. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT116.25 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-08), ACME Laboratories's current stock price is BDT83.30. ACME Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was BDT116.25. ACME Laboratories's Cyclically Adjusted PB Ratio of today is 0.72.

During the past 9 years, the highest Cyclically Adjusted PB Ratio of ACME Laboratories was 0.71. The lowest was 0.63. And the median was 0.66.


ACME Laboratories  (DHA:ACMELAB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ACME Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=83.30/116.25
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 9 years, the highest Cyclically Adjusted PB Ratio of ACME Laboratories was 0.71. The lowest was 0.63. And the median was 0.66.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ACME Laboratories Cyclically Adjusted Book per Share Related Terms


ACME Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ACME Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACME Laboratories Cyclically Adjusted Book per Share Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACME Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 113.65 116.25

DHA:ACMELAB vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Cyclically Adjusted PB Ratio falls into.


DHA:ACMELAB
90GF Score
ACME Laboratories Ltd DHA:ACMELAB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACME Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ACME Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=132.273/330.2130*330.2130
=132.273

Current CPI (Mar. 2026) = 330.2130.

ACME Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201603 0.000 238.132 0.000
201606 77.336 241.018 105.956
201609 0.000 241.428 0.000
201612 77.432 241.432 105.906
201703 79.268 243.801 107.363
201706 80.133 244.955 108.024
201709 82.137 246.819 109.889
201712 80.470 246.524 107.788
201803 82.319 249.554 108.926
201806 83.384 251.989 109.269
201809 85.214 252.439 111.468
201812 83.558 251.233 109.826
201903 85.316 254.202 110.827
201906 86.688 256.143 111.756
201909 88.566 256.759 113.903
201912 86.817 256.974 111.560
202003 88.478 258.115 113.192
202006 90.000 257.797 115.281
202009 91.988 260.280 116.704
202012 91.283 260.474 115.723
202103 93.114 264.877 116.082
202106 95.040 271.696 115.509
202109 97.826 274.310 117.762
202112 97.705 278.802 115.722
202203 100.084 287.504 114.952
202206 102.504 296.311 114.232
202209 105.427 296.808 117.293
202212 104.945 296.797 116.761
202303 107.480 301.836 117.585
202306 110.089 305.109 119.147
202309 113.203 307.789 121.450
202312 0.000 306.746 0.000
202403 115.322 312.332 121.924
202406 118.391 314.175 124.435
202409 121.019 315.301 126.743
202412 120.371 315.605 125.942
202503 123.183 319.799 127.194
202509 129.381 324.800 131.537
202512 128.969 324.054 131.420
202603 132.273 330.213 132.273

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of BDT116.25 mean?
ACME Laboratories (DHA:ACMELAB) has a Cyclically Adjusted Book per Share of BDT116.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ACME Laboratories and its competitors.
Is ACME Laboratories' Cyclically Adjusted Book per Share too high?
ACME Laboratories' current Cyclically Adjusted Book per Share is BDT116.25. Overall, ACME Laboratories has a GF Score™ of 90/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ACME Laboratories' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
ACME Laboratories' Cyclically Adjusted Book per Share of BDT116.25 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ACME Laboratories and its competitors. ACME Laboratories's current Cyclically Adjusted Book per Share is BDT116.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACME Laboratories stock overvalued right now?
Based on GuruFocus' analysis, ACME Laboratories (DHA:ACMELAB) is currently considered Possible Value Trap. The stock's GF Value™ is BDT125.35, compared to a current price of BDT83.30 — trading 33.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is BDT116.25. ACME Laboratories' overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ACME Laboratories (DHA:ACMELAB), the current Cyclically Adjusted Book per Share is BDT116.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?

Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued. The current stock price of BDT83.30 is trading 33.5% below its estimated GF Value™ of BDT125.35. GuruFocus considers ACME Laboratories to be Possible Value Trap.

Key valuation signals for DHA:ACMELAB:

  • Cyclically Adjusted Book per Share: BDT116.25
  • GF Value™: BDT125.35 vs. price of BDT83.30 (33.5% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ACME Laboratories Business Description

Address 1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
90GF Score

Get the complete analysis for DHA:ACMELAB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT83.30
Price
BDT125.35
GF Value